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Summary Isolated parent-offspring pairs could represent a valu-
able additional source of information but are uninfor-
Recently, data on loss of constitutional heterozygosity
mative without additional data. They can become infor-
(LOH) have been used by several groups to increase the
mative when LOH is included. Observations from the
power to detect linkage in pedigrees with an inherited
tumor of only one of the affected pedigree members can
cancer predisposition. This approach assumes that the
already provide indications regarding the location of the
predisposition is due to the inheritance of the defective marker with respect to the disease locus. Two such cases
copy of a tumor suppressor. In order to assess the gain are depicted in ﬁgure 1. In ﬁgure 1a, marker allele 2 is
of power expected from the inclusion of LOH data, retained in the parental tumor and is transmitted to the
we simulated segregation and somatic loss of alleles in affected offspring. This is consistent both with marker
pedigrees consisting of an affected pair of ﬁrst-degree allele 2 being located on the same chromosome as the
relatives. We explored the effects of pedigree structure, defective tumor-suppressor allele and with the marker
frequency of loss, penetrance, and recombination rate and tumor-suppressor loci being close enough for both
on the expected LOD score. The results indicate that, to be deleted by the same event and for no recombina-
for establishment of genetic linkage, isolated parent-off- tion to have happened between them. The pedigree and
spring pairs can be as informative as sib pairs and that typing depicted in ﬁgure 1b, where the allele retained in
they could represent an additional source of information the tumor is not the one transmitted to the affected child,
in linkage studies. would not support these assumptions.
In a previous paper we presented a framework for
the formal incorporation of LOH into linkage analysisRecently several groups have used data on loss of consti-
(Teare et al. 1994). This approach can be outlined astutional heterozygosity (LOH) to increase the power to
follows: For an individual with the genotype g, we incor-detect genetic linkage (Rebbeck et al. 1994; Steichen-
porate LOH as a component of the phenotype x:Gersdorf et al. 1994; Teare et al. 1994; Lustbader et al.
x Å (d,l), where d describes the disease status of the1995; Rohde et al. 1995). This approach is applicable
individual and l describes the genetic changes observedwhen the cancer predisposition is caused by the inheri-
at the marker locus in the tumor of this individual. Wetance of the defective copy of a tumor-suppressor gene.
can therefore partition the penetrance function P(xÉg):In this situation, inactivation of the wild-type allele in
P(xÉg) Å P(dÉg)P(lÉg,d). To describe P(lÉg,d)—that is,the tumor by deletion will be accompanied by loss of
the conditional probability of showing the LOH statusalleles at marker loci close to the tumor suppressor. The
l, given the genotype g and the disease status d—wealleles retained in the tumor will tend to originate from
introduced the parameters lij , eij , and r. lij and eij arethe same parent as the defective copy of the tumor-
the probabilities of observing a loss of one or both allelessuppressor gene.
at the marker locus, given the alleles i and j at the diseaseIn this communication we explore the consequences
locus (i,j √ {d,D}, where d designates wild-type allelethat incorporation of LOH has on both the expected
and D denotes the allele associated with cancer predis-LOD scores of isolated pairs of affected ﬁrst-degree rela-
position). The parameter r applies to the case when antives and the inﬂuence of various parameters. Sib pairs
individual heterozygous at the disease locus shows inare widely used to locate genes predisposing to disease.
the tumor the loss of one allele at the marker locus. r
describes the probability that the marker allele retained
in the tumor and the disease-predisposing allele do notReceived January 27, 1997; accepted for publication May 23, 1997.
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explored in ﬁgure 2. As in standard linkage analysis, the
more polymorphic the marker, the more information
can be extracted. Figure 2 shows that the expected LOD
scores for a MD pair and a SS pair become more similar
when the frequency of loss moves toward one. In the
case where no loss at the marker locus is observable,
the MD pair becomes uninformative. For a SS pair theFigure 1 Examples of affected parent-offspring pairs that be-
expected LOD score more than doubles for a frequencycome informative when LOH data are considered. We assume that
the mother’s tumor was typed. The numbers represent alleles at the of loss of .4. It is perhaps surprising that the expected
marker locus. Const. Å constitutional genotype; and Tumor Å geno- LOD score obtainable for a MD pair can be similar to
type of the tumor. that achieved for a SS pair, although, if a tumor is not
observed, the former is always uninformative. However,
we should bear in mind that, in the absence of linkage,
there is a .5 probability that a particular marker alleledefective (D) allele at the disease locus, the probability
of observing a loss at the marker locus, given that the present in one sister—that is, the allele retained in her
tumor—is shared, by descent, with the other sister. Thisretained marker allele and the cancer-predisposing allele
D were inherited on the same chromosome, is P(lÉg,d) is also the probability that a particular allele will be
shared between a mother and her daughter. For (mei-Å ldD(1 0 r). A more detailed discussion of this model,
as well as examples of its application, can be found in otic) recombination fraction u Å .00, these probabilities
are similar, and hence so are the LOD scores.the work of Teare et al. (1994) and Rohde et al. (1995).
In order to ascertain the gain of power expected from The frequency of loss at the marker locus may depend
not only on its location—in particular, with respect tothe inclusion of LOH data, we adapted the C version
of the SLINK program (Ott 1989; Weeks et al. 1990; the disease locus—but also on the genotype at the dis-
ease locus. Cornelis et al. (1995) reported LOH forCottingham et al. 1993) to simulate the segregation and
somatic loss of alleles. We implemented the modiﬁcation markers surrounding BRCA1 in 50 of 58 tumors from
members of families with disease predisposition linkedof the penetrance function in SLINK, as described for
MLINK elsewhere (Rohde et al. 1995). The modiﬁed to BRCA1. The retained alleles did always originate
from the same parent as did the disease predisposition.program can simulate LOH at autosomal and X-linked
loci in a variety of pedigrees. Its source code and some
examples are available via the anonymous ftp server at
ftp.mdc-berlin.de (login: anonymous; password: E-mail
address; ﬁle: lslink.tar.Z in the directory pub/linkage).
We used familial breast cancer linked to BRCA1 as a
model in our simulations, since LOH at loci surrounding
BRCA1 has been extensively studied in families with
disease predisposition linked and unlinked to this locus,
as well as in sporadic cases (Cornelis et al. 1995, and
references therein). Therefore, affected sib pairs were
represented by sister-sister (SS) pairs and parent-off-
spring pairs by mother-daughter (MD) pairs. The data
from Easton et al. (1993) were used both for the liability
classes and for the frequency of the predisposing allele
(fD). We assumed throughout the calculations that nor-
mal and tumor material were typed for each affected
individual, that affected individuals had only one tumor,
that no phenotypic or genotypic information was avail-
able for unaffected individuals, and that homozygous
losses are rare enough to be neglected (edd Å edD Å eDD
Å .00). For each set of parameters and pedigree, 1,000 Figure 2 Expected LOD scores for different frequencies of loss
and either eight (blackened symbols) or two (unblackened symbols)replicates were generated and analyzed by use of the
alleles at the marker locus, for affected pedigree members diagnosedmodiﬁed versions of MLINK or ILINK (Rohde et al.
with breast cancer before the age of 31 years (liabilities are .00002,1995).
.00167, and .00167 for the genotypes dd, dD, and DD, respectively);
It is intuitively clear that, the more frequently LOH fD Å .003, u Å .00, and r Å .00. Simulation and analysis were done
is observed, the more power we expect to gain. The by use of the same parameters. MD pairs are represented by circles,
and SS pairs are represented by squares.effects of the frequency of loss at the marker locus are
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Table 1
Effects That Frequencies of LOH Have on Expected LOD Scores, Depending on Genotype at Disease
Locus, for an SS Pair and an MD Pair
LOH FREQUENCIES USED IN
Analysis
AGE AT ONSET
(Penetrance for Age Simulation All l Å .3 l as in Simulation
Interval, by Genotype
[dd, dD, DD] ldd ldD lDD MD Pair SS Pair MD Pair SS Pair
.8 .8 .8 .30 .31 .30 .31õ 31 years (.00002,
.4 .8 .2 .31 .31 .32 .32.00167, .00167)
.2 .8 .2 .32 .32 .32 .33
.8 .8 .8 .03 .03 .03 .03
51–60 years (.00137,
.4 .8 .2 .04 .04 .06 .06.01711, .01711)
.2 .8 .2 .04 .04 .07 .08
NOTE.—The calculations were performed for eight alleles at the marker locus; fD Å .003, u Å .00, and r
Å .00. Unless speciﬁed otherwise, the same parameters were used for simulation and analysis.
For families that were unlinked or for which linkage to seem a reasonable choice in the absence of estimates for
the frequencies of loss, but, as the results from table 1BRCA1 was uncertain, LOH was detected in 9 of 19
tumors. Similar observations have been reported for suggest, it may result in loss of power.
The increase in power expected from the inclusion ofLOH at 13q in families with and without disease linked
to BRCA2 (Collins et al. 1995). LOH depends on the certainty with which we can infer
the phase between the cancer-predisposing allele and theThe effects of three different sets of LOH frequencies
on the expected LOD scores are shown in table 1. The marker allele retained in the tumor. The parameter r
describes the probability that these two alleles do notvalues for ldd and ldD in the second set are close to
the frequencies described by Cornelis et al. (1995). The originate from the same parent. This can happen either
when loss at the marker locus is unrelated to inactivationchoice of lDD Å .2 is arbitrary. It corresponds to the
average LOH frequency determined by Sato et al. (1990) at the disease locus or when there has been a recombina-
tion event between both loci after conception and priorfor a series of markers across the genome. It has little
inﬂuence on the calculations, given the low frequency to the occurrence of the deletion. Steichen-Gersdorf et
al. (1994) assumed r Å 0 for markers close to BRCA1.assumed for allele D. The third set of values (ldd Å .2,
ldD Å .8, and lDD Å .2) should help in the investigation This assumption seems justiﬁed in light of the results
reported by Cornelis et al. (1995). However, deletion ofof the effects of a larger difference between ldd and ldD .
Table 1 also shows that the expected LOD scores in- the allele mutated in the germ line has been observed in
tumors from members of Li-Fraumeni families with acrease the smaller ldd is with respect to ldD . The relative
increase is more marked the more similar the liability germ-line p53 mutation (Varley et al. 1997). It is possi-
ble that, in these cases, the retained allele has been inacti-values for a carrier and a noncarrier are. Misspeciﬁca-
tion of the frequencies of loss, as presented in table 1, vated during tumor development. This may be a phe-
nomenon particular to p53, but it illustrates that, evenresults in a drop in the expected LOD scores. In the ﬁrst
row for each liability class, either the ﬁrst and the third in cases in which marker and disease locus are very
close, to assume that the mutant allele is on the sameentries or the second and the fourth entries are identical.
In general, when the analysis is performed under the homologue as the marker alleles retained in the tumor
may result in a misspeciﬁcation of r. Figure 3 showsassumption that the frequency of loss is independent of
the genotype at the disease locus (i.e., ldd Å ldD Å lDD that the expected LOD score decreases with increasing
r, in particular for a MD pair as compared with a SSÅ l ú 0), the obtained LOD score is independent of the
speciﬁc value chosen for l, provided that data on the pair. Nevertheless, for r Å .2—that is, retention of ‘‘the
wrong allele’’ in one of ﬁve tumors—the expected LODnormal material are also available for every tumor
typed. This is equivalent to multiplying each value of a score for a MD pair is still as high as that expected for
a SS pair without LOH.liability class—that is, the penetrance for each possible
genotype—by a constant factor. Therefore, ldd Å ldD As shown in ﬁgure 4, when r is misspeciﬁed the maxi-
mum expected LOD score is achieved for a u differentÅ lDD Å l ú 0, edd Å edD Å eDD Å e § 0, and e / l
õ 1 (e ú 0, if homozygous losses have been observed) from the one used to generate the data—that is, misspec-
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Figure 5 Expected LOD scores for different u’s and frequenciesFigure 3 Expected LOD score for different values of r, for a SS
of loss, for a sib pair (blackened symbols) and aMD pair (unblackenedpair (squares) and a MD pair (circles), for affected pedigree members
symbols), for frequency of loss .8 (circles), .4 (squares), or .0 (trian-diagnosed with breast cancer before the age of 31 years, with eight
gles).alleles at the marker locus, frequency of loss .8 irrespective of the
genotype at the disease locus, and u Å .00. Simulation and analysis
were done by use of the same r values.
marked in a MD pair than in a SS pair. These observa-
tions suggest that r and u should be jointly estimated.
iﬁcation of the ‘‘postzygotic’’ recombination fraction Under some circumstances, MD pairs can be expected
not only decreases the obtainable LOD score to the ex- to be more informative than SS pairs. For a MD pair,
tent that any indication of linkage may vanish but also only one meiosis takes place between the affected rela-
results in a wrong estimate of u. This effect is more tives, whereas, even if both sisters have inherited the
same predisposing allele from the same parent, this allele
is involved in one meiosis for each sister. Therefore, for
constant r and increasing u, the expected LOD score
should decrease faster for a sib pair as compared with
a parent-offspring pair. Figure 5 shows, for example,
that, for an LOH frequency of .4 and a u Å .05, the
expected LOD score for a MD pair is higher than that
for a SS pair. These calculations were done under the
assumptions that deletions extending to the marker lo-
cus affect the wild-type allele at the disease locus and
that postzygotic recombination events between these
two loci are rare enough to be neglected. These assump-
tions are likely to be correct for small values of u.
In this communication we have investigated the gain
of power expected from inclusion of LOH information
in the analysis of genetic linkage of isolated pairs of
affected ﬁrst-degree relatives. We modiﬁed the SLINK
program to simulate segregation and somatic loss of
alleles in pedigrees. We have previously shown that iso-
Figure 4 Expected LOD score and estimate of u, by misspeciﬁ- lated parent-offspring pairs can be used for establish-
cation of r for a SS pair (squares) and a MD pair (circles); parameters ment of genetic linkage when LOH information is in-
are the same as those used in ﬁgure 3. Under the assumption of r cluded. We report here that, for loci with a high LOHÅ .00 in the analysis, maximum-likelihood estimates of u (unblack-
frequency and consistent loss of the wild-type allele inened symbols) were determined by use of a modiﬁed version of ILINK
the tumor, isolated parent-offspring pairs can be ex-(Rohde et al. 1995). The blackened symbols denote the corresponding
expected LOD scores. pected to be as informative as sib pairs. Therefore, iso-
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